Heres Why
Metformin therapy and cognitive dysfunction in patients with type 2 diabetes: a meta-analysis and systematic review
His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches
In other words, the researchers looked at the treated group only after they were exposed to GLP-1s, when their BMIs had likely fallen lower than their pre-prescription weights, the commentary writers noted
When your blood volume drops too far, your kidneys get less of the flow they need to do their job
Determining an appropriate GLP-1 receptor agonist hinges on various factors including personal preference, financial considerations, administration frequency, along with specific health conditions that patients might have
